Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human microsomes

Xenobiotica

Volumn 26, Issue 3, 1996, Pages 275-284

  Jaeger, W ^a,b   Benet, L Z ^a   Bornheim, L M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIDIOL; CYCLOSPORIN; CYTOCHROME P450; DRUG METABOLITE; TETRAHYDROCANNABINOL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; HUMAN; HUMAN TISSUE; LIVER MICROSOME; MALE; MOUSE; NONHUMAN;

ANIMALIA;

EID: 0029917596     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.3109/00498259609046707     Document Type: Article

References (22)

1. BENOWITZ, N. L., NGUYEN, T., JONES, R. T., HERNING, R. I., and BACHMAN, J., 1980, Metabolic and psychophysiologic studies of cannabidiol-hexobarbital interaction. Clinical Pharmacology and Therapeutics, 28, 115-120.
2. BERTAULT-PERES, P., BONFILS, C., FABRE, G., JUST, S., CANO, J. P., and MAUREL, P., 1987, Metabolism of cyclosporin A. II. Implication of the macrolide antibiotic inducible cytochrome P-450 3c from rabbit liver microsomes. Drug Metabolism and Disposition, 15, 391-398.
3. BORNHEIM, L. M., 1989, Effect of cannabidiol on drug metabolism. In Biochemistry and Physiology of Substance Abuse, edited by R. R. Watson (CRC Press: Boca Raton), vol. 1, pp. 21-35.
4. BORNHEIM, L. M., BORYS, H. K., and KARLER, R., 1981, Effect of cannabidiol on cytochrome P-450 and hexobarbital sleep time. Biochemical Pharmacology, 30, 503-507.
5. BURNHEIM, L. M., and CORREIA, M. A., 1990, Selective inactivation of mouse liver cytochrome P-450IIIA by cannabidiol. Molecular Pharmacology, 38, 319-326.
6. BORNHEIM, L. M. and CORREIA, M. A., 1991, Purification and characterization of the major hepatic cannabinoid hydroxylase in mouse: a possible member of the cytochrome P-450IIC subfamily. Molecular Pharmacology, 40, 228-234.
7. BORNHEIM, L. M., EVERHART, E. T., LI, J., and CORREIA, M. A., 1993, Characterization of cannabidiol-mediated cytochrome P450 inactivation. Biochemical Pharmacology, 45, 1323-1331.
8. BORNHEIM, L. M., LASKER, J. M., and RAUCY, J. L., 1992, Human hepatic microsomal metabolism of Δ1-tetrahydrocannabidiol. Drug Metabolism and Disposition, 20, 241-246.
9. COMBALBERT, J., FABRE, I., DALET, I., DERANCOURT, J., CANO, J. P., and MAUREL, 1989, Metabolism of cyclosporin A. IV. Purification and identification of rifampin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P-450 IIIA gene family. Drug Metabolism and Disposition, 17, 197-207.
10. FAIRBAIRN, J. W., and LIEBMAN, J. A., 1973, The cannabinoid content of Cannabis sativa L. grown in England. Journal of Pharmacy and Pharmacology, 26, 413-419.
11. FETTERMAN, P. S., KEITH, E. S., WALLER, C. W., GUERRERO, O., DOORENBOS, N. J., and QUIMBY, M. W., 1971, Mississippi-grown Cannabis sativa L.: preliminary observation on chemical definition of phenotype and variation in tetrahydrocannabinol content versus age, sex, and plant part. Journal of Pharmaceutical Sciences, 60, 1246-1249.
12. KRONBACH, T., FISCHER, V., and MEYER, U. A., 1988, Cyclosporine metabolism in human liver: identification of a cytochrome P450 III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clinical Pharmacology and Therapeutics, 43, 630-635.
13. LOWRY, O. H., ROSENBROUGH, N. J., FARR, A. L., and RANDALL, R. J., 1951. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
14. MAUREH, G., LOOSLI, H. R., SCHREIER, E., and KELLER, B., 1984, Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites. Drug Metabolism and Disposition, 12, 120-127.
15. MAYER, R. D., BERMAN, S., COCKETT, A. T. K., and MAINES, M. D., 1989, Differential effects of cyclosporin on hepatic renal heme, cytochrome P-450 and drug metabolism - possible role in nephrotoxicity of the drug. Biochemical Pharmacology, 38, 1001-1007.
16. OMURA, T., and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes II. Solubilization, purification, and properties. Journal of Biological Chemistry, 239, 2370-2378.
17. PRUEKSARITANONT, T., CORREIA, M. A., RETTIE, A. E., SWINNEY, D. C., THOMAS, P. E., and BENET, L. Z., 1993, Cyclosporine metabolism by rat liver microsomes-evidence for involvement of enzyme(s) other than cytochromes P-450 3A. Drug Metabolism and Disposition, 21, 730-737.
18. PICHARD, L., FABRE, L., FABRE, I., DOMERGUE, J., AUBERT, B. S., MOURAD, G., and MAUREL, P., 1990, Cyclosporine A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metabolism and Disposition, 18, 595-606.
19. SHEETS, J. J., and MASON, J. I., 1984, Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver. Drug Metabolism and Disposition, 12, 603-607.
20. SIEMENS, A. J., KALANT, H., KHANNA, J. M., MARSHMAN, J., and HO, G., 1974, Effect of cannabis on pentobarbital-induced sleeping time and pentobarbital metabolism in the rat. Biochemical Pharmacology, 23, 477-488.
21. VAN DER HOEVEN, T. A., and COON, M. J., 1974, Preparation and properties of partially purified cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase from rabbit liver microsomes. Journal of Biological Chemistry, 249, 6302-6310.
22. WATANABE, K., ARAI, M., NARIMATSU, S., YAMAMOTO, I., and YOSHIMURA, H., 1987, Self-catalyzed inactivation of cytochrome P-450 during microsomal metabolism of cannabidiol. Biochemical Pharmacology, 36, 3371-3377.